In a significant move to address the escalating prevalence of urological conditions in the United States, Olympus Corporation has officially announced the launch of its Soltive Gemini 60W Laser System. This next-generation thulium fibre laser (TFL) platform represents a strategic advancement in both kidney stone management and soft tissue surgical interventions, offering a sophisticated suite of features designed to enhance clinical precision, patient safety, and operational versatility.
The introduction of the Soltive Gemini comes at a critical juncture for the US healthcare sector, as clinicians grapple with an increasing volume of patients requiring minimally invasive urological procedures. By integrating proprietary technologies such as "StoneSense," Olympus aims to set a new benchmark for safety and efficiency in the operating room.
The Core Innovation: StoneSense Technology
At the heart of the Soltive Gemini system is the innovative StoneSense technology. During traditional endoscopic fragmentation—a procedure used to break down kidney stones—the risk of mucosal tissue injury is a persistent concern. The high-energy nature of lasers can inadvertently damage the delicate lining of the urinary tract if the laser beam strikes tissue rather than the target calculus.
StoneSense mitigates this risk through a real-time feedback loop. The system is engineered to automatically detect whether the surgical fibre is properly aimed at a stone or if it is in contact with surrounding anatomy. When the laser emission is not directed at a stone, the system halts energy delivery, effectively providing a safeguard against accidental tissue trauma. This intelligent automation allows surgeons to perform lithotripsy with a greater degree of confidence, potentially reducing postoperative complications and improving recovery times for patients.
A Multifaceted Surgical Tool: Six Modes of Operation
The versatility of the Soltive Gemini is underscored by its inclusion of six distinct pulse options, each engineered for specific clinical scenarios. This modularity allows urologists to adapt their surgical strategy mid-procedure without the need to switch equipment.
1. Continuous Wave Mode
Designed for steady, consistent energy delivery, this mode is the primary tool for tissue coagulation and vaporisation. Its stability ensures that surgeons can maintain a controlled field, which is essential during complex soft tissue procedures.
2. Enucleation Pulse
This mode is specifically calibrated to establish a consistent coagulation boundary. By providing superior haemostasis compared to standard thulium pulses, the Enucleation Pulse is particularly effective during procedures like laser enucleation of the prostate, where controlling bleeding is paramount to maintaining a clear visual field.
3. Fragmentation Pulse
Optimised for the primary goal of lithotripsy, this mode allows for the efficient ablation of stones into larger fragments, facilitating easier extraction or spontaneous passage.
4. Minimal Carbonisation Pulse
Precision is critical during excision and incision procedures. The Minimal Carbonisation mode limits tissue charring, which not only preserves the integrity of the surrounding healthy tissue but also improves the quality of biopsy samples if tissue analysis is required.
5. Minimal Retropulsion Pulse
A common challenge in lithotripsy is "retropulsion," where the stone is pushed away by the force of the laser pulse, making it difficult to target. This mode restricts stone movement, ensuring that smaller stones (typically under 5mm) remain stationary for more efficient treatment.
6. Regular Mode
Providing a flat-top pulse profile, the Regular mode serves as a reliable workhorse for both standard lithotripsy and general soft tissue applications, ensuring consistent performance for routine cases.
Furthermore, the system features a "Guided Mode." Developed in close collaboration with international endourology specialists, this interface assists clinicians in selecting the optimal operational parameters for a wide array of interventions, including stone management and benign prostatic hyperplasia (BPH) treatment.
Official Perspective: Driving Innovation in Urology
The launch of the Soltive Gemini reflects Olympus’s broader corporate strategy to lead in the surgical and interventional solutions space. Seiji Kuramoto, Executive Officer and Head of the Surgical and Interventional Solutions Division at Olympus, emphasised the company’s patient-centric philosophy during the announcement.
"Olympus is driven to bring new innovation to the market, providing physicians with the tools to help them meet their clinical goals," Kuramoto stated. "As part of our commitment to patient focus, we are excited to launch Soltive Gemini, which offers flexibility to tailor energy delivery. The advanced technology featured in Olympus’s newest thulium fibre laser platform offers clinicians versatility and control to help provide their patients with the best possible care."
This commitment to innovation is not merely about the hardware itself but about the integration of clinical intelligence into the surgical workflow. By empowering surgeons with technology that responds to the environment, Olympus is shifting the paradigm from purely manual control to "assisted" surgery.
Chronology of Innovation: Building the Olympus Ecosystem
The launch of the Soltive Gemini is the latest in a series of strategic technology rollouts by Olympus. The company has been systematically upgrading its portfolio to ensure it remains at the forefront of the endoscopic and surgical imaging markets.
- March 2026: Olympus launched the VISERA ELITE III surgical imaging platform in the US. Designed to enhance visualisation, the platform provides high-definition imaging, improved workflow efficiency, and cross-specialty flexibility.
- Late 2026: The commercial rollout of the Soltive Gemini 60W Laser System marks the expansion of the company’s laser lithotripsy portfolio, directly complementing the advanced imaging capabilities of the VISERA series.
By aligning its imaging and energy-delivery platforms, Olympus is creating a cohesive surgical ecosystem. Surgeons who use the VISERA ELITE III for visualisation are now equipped with the Soltive Gemini for therapeutic intervention, creating a seamless transition from diagnosis to treatment.
Implications for the US Healthcare Landscape
The clinical necessity for such advanced technology is driven by shifting epidemiological trends. Kidney stones have become an increasingly common diagnosis in the US, with recent studies suggesting that the incidence rate is rising due to factors including dietary habits, climate change, and metabolic health issues.
Reducing Healthcare Costs
Beyond clinical outcomes, the Soltive Gemini has significant economic implications. By reducing the incidence of mucosal injury and improving the efficiency of stone fragmentation, the system can potentially shorten operating room times. In the current fee-for-service and value-based care models, shorter procedures and fewer complications translate to higher throughput for hospitals and reduced total cost of care for payers.
Training and Safety
Olympus has been clear that the efficacy of the Soltive Gemini is contingent upon proper usage. The system is restricted to healthcare professionals who have undergone rigorous training in laser safety and have thoroughly studied the accompanying instructions for use. This emphasis on training ensures that the advanced features—specifically the various pulse modes—are utilised to their full potential, maintaining the highest standards of safety in complex endoscopic environments.
Future Outlook
As urology continues to evolve toward increasingly minimally invasive techniques, the role of high-precision laser platforms will only grow. The Soltive Gemini represents a convergence of hardware, software, and clinical expertise. By addressing the fundamental challenges of lithotripsy—such as retropulsion, tissue damage, and haemostasis—Olympus has positioned itself as a critical partner for hospitals aiming to modernise their urological departments.
As healthcare providers face pressure to improve patient outcomes while managing the rising demand for surgical services, technologies that offer both safety and speed will likely become the standard. With the Soltive Gemini, Olympus is not just launching a new device; it is providing a sophisticated solution to a complex, systemic healthcare challenge, reinforcing its reputation as a pioneer in medical technology.
Disclaimer: The Soltive Gemini 60W Laser System is intended for use by trained healthcare professionals. Clinical use should strictly adhere to the manufacturer’s instructions and established hospital safety protocols.
About the Author
